神经激素对抗慢性克制压力诱导的头发生长抑制
Lingjing Chen1, Qing Yu2,3, Feiying Guo2,4
1Department of Dermatology, Hangzhou Children's Hospital, Hangzhou, China.
Experimental dermatology
|December 10, 2023
概括
神经激素 (NTS) 通过调节毛囊中的基因表达来抵消压力引起的脱发. 这种神经是一种潜在的治疗点,用于控制压力引起的头发生长抑制.
科学领域:
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
- 神经内分泌学神经内分泌学
背景情况:
- 压力是通过神经内分泌-毛囊 (HF) 轴引起脱发的已知触发因素.
- 神经激素 (NTS),一种神经,与皮肤疾病有关,但其在压力引起的脱发中的作用尚不清楚.
研究的目的:
- 研究NTS在压力诱导的头发生长抑制中的功能和分子机制.
- 确定NTS在压力条件下如何影响人类皮肤乳头细胞 (HDPCs) 的基因表达.
主要方法:
- 慢性克制压力 (CRS) 应用于小鼠以诱导压力.
- 用RNA测序和ELISA测量NTS和神经素受体 (Ntsr) 在小鼠皮肤中的表达.
- 皮内NTS注射给压力大的小鼠.
- 对用NTS.治疗的HDPC进行了基因表达分析 (GO和KEGG丰富).
主要成果:
- 在小鼠皮肤中,CRS显著降低了NTS和Ntsr的表达.
- 在小鼠中,NTS注射抵消了CRS诱导的头发生长抑制.
- NTS调节了HDPC中的1093个基因,影响了DNA复制,细胞周期,血管生成,Hippo信号传递和Wnt信号传递途径.
结论:
- NTS对应激诱导的头发生长抑制起着保护作用.
- 在基因转录水平上,NTS调节了参与毛囊生物学的关键细胞通路.
- NTS代表了管理与压力相关的脱发的潜在治疗目标.
相关概念视频
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...


